Literature DB >> 26669475

A Compartmentalized Profibrotic Immune Response Characterizes Pericardial Tuberculosis, Irrespective of HIV-1 Infection.

Kerryn Matthews1, Armin Deffur1, Mpiko Ntsekhe1, Faisal Syed1, James B W Russell1, Kemi Tibazarwa1, Janine Wolske1, Johan Brink1, Bongani M Mayosi1, Robert J Wilkinson1,2,3, Katalin A Wilkinson1,2.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26669475      PMCID： PMC4731721          DOI： 10.1164/rccm.201504-0683LE

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  10 in total

Review 1.  Tuberculous pericarditis with and without HIV.

Authors:  Mpiko Ntsekhe; Bongani M Mayosi
Journal:  Heart Fail Rev       Date:  2013-05       Impact factor: 4.214

2.  Health and health care in South Africa--20 years after Mandela.

Authors:  Bongani M Mayosi; Solomon R Benatar
Journal:  N Engl J Med       Date:  2014-09-29       Impact factor: 91.245

Review 3.  A long-awaited merger of the pathways mediating host defence and programmed cell death.

Authors:  J Magarian Blander
Journal:  Nat Rev Immunol       Date:  2014-09       Impact factor: 53.106

4.  Cytokine production in patients with tuberculous pericarditis.

Authors:  L J Burgess; H Reuter; M E Carstens; J J F Taljaard; A F Doubell
Journal:  Int J Tuberc Lung Dis       Date:  2002-05       Impact factor: 2.373

5.  Cytokine production at the site of disease in human tuberculosis.

Authors:  P F Barnes; S Lu; J S Abrams; E Wang; M Yamamura; R L Modlin
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

6.  Prednisolone and Mycobacterium indicus pranii in tuberculous pericarditis.

Authors:  Bongani M Mayosi; Mpiko Ntsekhe; Jackie Bosch; Shaheen Pandie; Hyejung Jung; Freedom Gumedze; Janice Pogue; Lehana Thabane; Marek Smieja; Veronica Francis; Laura Joldersma; Kandithalal M Thomas; Baby Thomas; Abolade A Awotedu; Nombulelo P Magula; Datshana P Naidoo; Albertino Damasceno; Alfred Chitsa Banda; Basil Brown; Pravin Manga; Bruce Kirenga; Charles Mondo; Phindile Mntla; Jacob M Tsitsi; Ferande Peters; Mohammed R Essop; James B W Russell; James Hakim; Jonathan Matenga; Ayub F Barasa; Mahmoud U Sani; Taiwo Olunuga; Okechukwu Ogah; Victor Ansa; Akinyemi Aje; Solomon Danbauchi; Dike Ojji; Salim Yusuf
Journal:  N Engl J Med       Date:  2014-09-01       Impact factor: 91.245

7.  Fibrotic response as a distinguishing feature of resistance and susceptibility to pulmonary infection with Mycobacterium tuberculosis in mice.

Authors:  Jean-François Marquis; André Nantel; Ronald LaCourse; Lynn Ryan; Robert J North; Philippe Gros
Journal:  Infect Immun       Date:  2007-10-15       Impact factor: 3.441

8.  Predominance of interleukin-22 over interleukin-17 at the site of disease in human tuberculosis.

Authors:  Kerryn Matthews; Katalin A Wilkinson; Barbara Kalsdorf; Teri Roberts; Andreas Diacon; Gerhard Walzl; Janine Wolske; Mpiko Ntsekhe; Faisal Syed; James Russell; Bongani M Mayosi; Rodney Dawson; Keertan Dheda; Robert J Wilkinson; Willem A Hanekom; Thomas J Scriba
Journal:  Tuberculosis (Edinb)       Date:  2011-07-20       Impact factor: 3.131

9.  HIV-1 infection alters CD4+ memory T-cell phenotype at the site of disease in extrapulmonary tuberculosis.

Authors:  Kerryn Matthews; Mpiko Ntsekhe; Faisal Syed; Thomas Scriba; James Russell; Kemi Tibazarwa; Armin Deffur; Willem Hanekom; Bongani M Mayosi; Robert J Wilkinson; Katalin A Wilkinson
Journal:  Eur J Immunol       Date:  2012-01       Impact factor: 5.532

10.  Prevalence, hemodynamics, and cytokine profile of effusive-constrictive pericarditis in patients with tuberculous pericardial effusion.

Authors:  Mpiko Ntsekhe; Kerryn Matthews; Faisal F Syed; Armin Deffur; Motasim Badri; Patrick J Commerford; Bernard J Gersh; Katalin A Wilkinson; Robert J Wilkinson; Bongani M Mayosi
Journal:  PLoS One       Date:  2013-10-14       Impact factor: 3.240
  10 in total
  6 in total

Review 1.  Tuberculous pericardial disease: a focused update on diagnosis, therapy and prevention of complications.

Authors:  Kishendree Naicker; Mpiko Ntsekhe
Journal:  Cardiovasc Diagn Ther       Date:  2020-04

2.  T cell responses to Mycobacterium indicus pranii immunotherapy and adjunctive glucocorticoid therapy in tuberculous pericarditis.

Authors:  Pia Steigler; Mukesh Chhiba; Veronica Francis; Alana Keyser; Deborah Abrahams; Willem Hanekom; Mpiko Ntsekhe; Thomas J Scriba
Journal:  Vaccine X       Date:  2022-06-14

3.  Effect of prednisolone on inflammatory markers in pericardial tuberculosis: A pilot study.

Authors:  Justin Shenje; Rachel P Lai; Ian L Ross; Bongani M Mayosi; Robert J Wilkinson; Mpiko Ntsekhe; Katalin A Wilkinson
Journal:  Int J Cardiol Heart Vasc       Date:  2017-11-03

Review 4.  Diagnosis and Management of Tuberculous Pericarditis: What Is New?

Authors:  Godsent Isiguzo; Elsa Du Bruyn; Patrick Howlett; Mpiko Ntsekhe
Journal:  Curr Cardiol Rep       Date:  2020-01-15       Impact factor: 2.931

5.  Comprehensive molecular characterization of circRNA-associated ceRNA network in constrictive pericarditis.

Authors:  Yixin Chen; Feifei Sun; Yong Zhang; Guang Song; Wei Qiao; Ke Zhou; Sihua Ren; Qian Zhao; Weidong Ren
Journal:  Ann Transl Med       Date:  2020-04

6.  Correlation between Blood and CSF Compartment Cytokines and Chemokines in Subjects with Cryptococcal Meningitis.

Authors:  Elizabeth C Okafor; Katherine H Hullsiek; Darlisha A Williams; James E Scriven; Joshua Rhein; Henry W Nabeta; Abdu K Musubire; Radha Rajasingham; Conrad Muzoora; Charlotte Schutz; Graeme Meintjes; David B Meya; David R Boulware
Journal:  Mediators Inflamm       Date:  2020-10-29       Impact factor: 4.711
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.